ES2186059T3 - Empleo de ectoina e hidroxiectoina como medicamento. - Google Patents

Empleo de ectoina e hidroxiectoina como medicamento.

Info

Publication number
ES2186059T3
ES2186059T3 ES98113132T ES98113132T ES2186059T3 ES 2186059 T3 ES2186059 T3 ES 2186059T3 ES 98113132 T ES98113132 T ES 98113132T ES 98113132 T ES98113132 T ES 98113132T ES 2186059 T3 ES2186059 T3 ES 2186059T3
Authority
ES
Spain
Prior art keywords
hydroxyectoine
ectoin
medicinal product
cells
state
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98113132T
Other languages
English (en)
Inventor
Erwin A Dr Galinski
Hans G Prof Dr Truper
Thomas Sauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bitop AG
Original Assignee
Bitop AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop AG filed Critical Bitop AG
Application granted granted Critical
Publication of ES2186059T3 publication Critical patent/ES2186059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA LA RECUPERACION IN VIVO DE SUSTANCIAS INTERNAS DE LAS CELULAS, EN EL CUAL LAS CELULAS ESTAN EN UN PRIMER ESTADO EN EL QUE EXISTEN UNAS CONDICIONES CASI ESTACIONARIAS ENTRE CELULA Y AMBIENTE, SE CAMBIAN DE REPENTE A UN SEGUNDO ESTADO, EN EL CUAL LAS CELULAS ESTAN OBLIGADAS A REACCIONAR EXPULSANDO SUSTANCIAS INTERNAS AL EXTERIOR, PARA CONSEGUIR ADAPTARSE A LAS CONDICIONES DEL SEGUNDO ESTADO.
ES98113132T 1992-12-31 1993-12-24 Empleo de ectoina e hidroxiectoina como medicamento. Expired - Lifetime ES2186059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4244580A DE4244580A1 (de) 1992-12-31 1992-12-31 Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen

Publications (1)

Publication Number Publication Date
ES2186059T3 true ES2186059T3 (es) 2003-05-01

Family

ID=6476850

Family Applications (2)

Application Number Title Priority Date Filing Date
ES98121244T Expired - Lifetime ES2234065T3 (es) 1992-12-31 1993-12-24 Procedimiento para la obtencion en vivo de contenidos de celulas.
ES98113132T Expired - Lifetime ES2186059T3 (es) 1992-12-31 1993-12-24 Empleo de ectoina e hidroxiectoina como medicamento.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES98121244T Expired - Lifetime ES2234065T3 (es) 1992-12-31 1993-12-24 Procedimiento para la obtencion en vivo de contenidos de celulas.

Country Status (7)

Country Link
EP (4) EP1493432A1 (es)
AT (3) ATE226943T1 (es)
DE (4) DE4244580A1 (es)
DK (2) DK0887418T3 (es)
ES (2) ES2234065T3 (es)
PT (1) PT887418E (es)
WO (1) WO1994015923A2 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342560A1 (de) * 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE4427617B4 (de) * 1994-08-04 2005-09-01 bitop Aktiengesellschaft für biotechnische Optimierung Verfahren zur Gewinnung von Zellinhaltsstoffen aus halophilen und osmophilen sowie halo- und osmotoleranten Mikroorganismen
DE19711082A1 (de) * 1997-03-18 1998-09-24 Degussa Verfahren zur Abtrennung von Tetrahydropyrimidinen aus wäßrigen Lösungen
JP2003501479A (ja) * 1999-06-12 2003-01-14 ビトプ ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬 剤
EP1125583A1 (de) * 2000-02-14 2001-08-22 Bitop Gesellschaft für biotechnische Optimierung MbH Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren
DE10014632A1 (de) * 2000-03-24 2001-09-27 Merck Patent Gmbh Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz der Streßproteine in der Haut
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
DE10214257A1 (de) 2002-03-28 2003-10-16 Merck Patent Gmbh Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden
DE10330768A1 (de) 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
WO2005113147A2 (en) 2004-04-08 2005-12-01 Biomatrica, Inc. Integration of sample storage and sample management for life science
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
DE102007003765A1 (de) 2007-01-19 2008-07-24 Farco-Pharma Gmbh Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz
DE102007013857A1 (de) 2007-03-20 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzungen, insbesondere für die topische Behandlung von Hauterkrankungen
DE102007052380A1 (de) 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
DE102008006780A1 (de) * 2008-01-30 2009-08-06 Bitop Ag Verwendung von Tetrahydropyrimidinen
DE102008036725B4 (de) 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung für die nasale Applikation
DE102008045237B4 (de) 2008-08-28 2010-07-29 Helmholtz-Zentrum Für Umweltforschung Gmbh - Ufz Verfahren zur simultanen Produktion von PHA und kompatiblen Soluten in halophilen Bakterien
EP2168570B1 (en) 2008-09-30 2013-12-25 Symrise AG Extracts of isochrysis sp.
EP2193785B1 (en) 2008-12-05 2018-07-18 Symrise AG Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes
DE102010010278A1 (de) * 2009-03-07 2010-09-16 Hertel, Marcus, Dr. Ing. Verfahren und Vorrichtung zur Bierherstellung
EP2430195B1 (en) 2009-05-11 2019-01-23 Biomatrica, INC. Compositions and methods for biological sample storage
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
DE102011113059A1 (de) 2011-09-09 2013-03-14 Bitop Ag Therapeutische Anwendungen von Ectoin
DE102012000416A1 (de) 2011-11-24 2013-05-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Applikation II
DE202012000250U1 (de) 2011-11-24 2012-12-05 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung I
DE102011122236A1 (de) 2011-12-09 2013-06-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung bei entzündlichen Erkrankungen der Haut und/oder Schleimhaut
EP2636750A1 (en) 2012-03-06 2013-09-11 Roche Diagniostics GmbH Compatible solute ectoine as well as derivatives thereof for enzyme stabilization
DE102012005177A1 (de) * 2012-03-16 2013-09-19 Bitop Ag Organlagerlösung
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
ES2643590T3 (es) 2014-03-18 2017-11-23 Symrise Ag Dióxido de titanio revestido para reducir el efecto de blanqueamiento en la piel
ES2819207T3 (es) 2014-04-29 2021-04-15 Symrise Ag Mezclas activas
ES2786373T3 (es) 2014-06-10 2020-10-09 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
EP3045161B1 (en) 2015-01-18 2026-03-25 Symrise AG Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions
KR20250047404A (ko) 2015-12-08 2025-04-03 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
DE202017101350U1 (de) 2017-02-24 2018-02-27 Farco-Pharma Gmbh Zusammensetzung, insbesondere Gel, zur Anwendung im Urogenitaltrakt
EP3592329B1 (en) 2017-03-06 2026-02-18 SUSONITY Commercial GmbH Use of compatible solutes
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
KR20220042171A (ko) 2019-08-01 2022-04-04 메르크 파텐트 게엠베하 각질화 장애의 예방 및 감소 및 관련 미용제
EP4424809A1 (en) 2023-03-03 2024-09-04 FCC Aqualia, S.A. Method for converting methane-containing gas streams into osmolytes using a bacteria culture in a taylor-flow bioreactor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286660A (en) * 1979-03-23 1981-09-01 Gesellschaft Fur Biotechnologische Forschung Gmbh Process and installation for the flooding of petroleum deposits and oil shale
US4720458A (en) * 1983-10-19 1988-01-19 Sullivan Cornelius W Heat sensitive bacterial alkaline phosphatase
DE3515650A1 (de) * 1985-05-02 1986-11-06 Biochemie GmbH, Kundl, Tirol Verfahren zur abtrennung von biotechnologisch hergestellten wertstoffen durch querstrom-mikrofiltration
JPH0759545B2 (ja) * 1987-06-17 1995-06-28 富士写真フイルム株式会社 塩基プレカ−サ−
FR2635113B1 (fr) * 1988-08-05 1992-07-24 Sanofi Sa Procede d'obtention d'interleukine-1 (beta) mature a partir de cellules d'e. coli transformees
JPH0331265A (ja) * 1989-06-26 1991-02-12 Takeda Chem Ind Ltd テトラヒドロピリミジン誘導体の製造方法
AU671071B2 (en) * 1990-08-30 1996-08-15 State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University, Portland, Oregon, and The University of Oregon, Eugene, Oregon, Johnson Hall, Substituted amidines having high binding to the sigma receptor and the use thereof
IL100810A (en) * 1992-01-30 1996-12-05 Yeda Res & Dev Pharmaceutical preparations including 2 - methyl - carboxy - 5 - hydroxy - tetrahydropyrimidine and / or 2 - methyl - 4 - carboxy - tetrahydropyrimidine, plywood methods

Also Published As

Publication number Publication date
ATE226943T1 (de) 2002-11-15
EP0677044B1 (de) 1998-10-28
DE4244580A1 (de) 1994-07-07
EP1493432A1 (de) 2005-01-05
EP0887418A2 (de) 1998-12-30
PT887418E (pt) 2003-03-31
EP0887418A3 (de) 1999-01-13
DE59309101D1 (de) 1998-12-03
EP0915167A1 (de) 1999-05-12
ATE172750T1 (de) 1998-11-15
DE59310311D1 (de) 2002-12-05
DE59310369D1 (de) 2005-01-13
ATE284448T1 (de) 2004-12-15
WO1994015923A3 (de) 1994-09-29
EP0677044A1 (de) 1995-10-18
EP0915167B1 (de) 2004-12-08
DK0887418T3 (da) 2003-02-24
DK0677044T3 (da) 1999-07-12
ES2234065T3 (es) 2005-06-16
WO1994015923A2 (de) 1994-07-21
EP0887418B1 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
ES2186059T3 (es) Empleo de ectoina e hidroxiectoina como medicamento.
ATE39905T1 (de) Undurchlaessige zellenfoermige schalenverpackung, die den gasaustausch zwischen den zellen zulaesst.
ES2178708T3 (es) Copolimeros segmentados de polidiorganosiloxanos y poliurea, y un procedimiento para obtenerlos.
ES2163527T3 (es) Transferencia de moleculas hacia el interior del citosol de las celulas por medio de sustancias fotosensibilizadoras.
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
ES2174798T3 (es) Sistemas de microbombas y microvalvulas elastomericas.
MX9203200A (es) Analogos de cc. 1065 novedosos.
SG129892G (en) Chemiluminescent composition
ES2176885T3 (es) Disolucion sin gel.
AR012378A1 (es) Composicion para la deteccion de gases electrofilicos y metodos de utilizacion de la misma.
GB1493775A (en) Chemical oxygen generator cells
ATE246615T1 (de) Hybridgasgenerator mit einem bohrpfosten
MX9303127A (es) Metodo para reducir selectivamente la poblacion celular de leucocitos.
ES2104195T3 (es) Procedimiento para la preparacion de carbodiimidas organicas.
ES2000871A6 (es) Un procedimiento para producir un copolimero de bloques selectivamente hidrogenado y fuoncionalizado
EA200500375A1 (ru) Способы увеличения продукции тромбоцитов и гематопоэтических стволовых клеток
ES2058862T3 (es) Conjunto de una capsula de apertura y de un recipiente con gollete de materia plastica, y su utilizacion.
ES2063121T3 (es) Material polimero organico y membrana de intercambio ionico producida a partir del mismo.
AU4455385A (en) 3- aminocarbonylmethoxy - 5 - phenylpyrazole derivatives
ES2043136T3 (es) Proceso catalitico para la preparacion de oximas.
ES2086148T3 (es) Procedimiento para la obtencion de cloro-fluor-butenos.
EA200400959A1 (ru) Кронен-пробка
RU2000122471A (ru) Отсек силовой конструкции
ES2036523T3 (es) 4-aminoarildihidropiridinlactonas, procedimiento para su obtencion y su empleo en medicamentos.
ES2138362T3 (es) Derivados de citisina con contenido de fosforo.